HER2 Support Group Forums - View Single Post - SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of

News · 07-22-2020, 09:17 PM

Diagnostics company SphingoTec GmbH today announced the launch of its IB10 sphingotest bio-ADM, a CE-IVD-marked point-of-care test to quantitatively determine blood levels of Bioactive Adrenomedullin (bio-ADM).

More...

07-22-2020, 09:17 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,960	SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of Diagnostics company SphingoTec GmbH today announced the launch of its IB10 sphingotest bio-ADM, a CE-IVD-marked point-of-care test to quantitatively determine blood levels of Bioactive Adrenomedullin (bio-ADM). More...